Answers are grounded in this paper and cite their sources.
Innovative GPU-accelerated methods improved prediction accuracy and chemical space in virtual ligand screening, identifying inhibitors for PD-L1 and K-Ras G12D.
To accelerate virtual ligand screening (VLS) and identify potent drug leads from massive chemical libraries, we developed two GPU-accelerated methods: Rapid Docking GPU Engine (RIDGE) for receptor-based screening and Rapid Isostere Discovery Engine (RIDE) for ligand-based 3D similarity screening. RIDGE performance surpassed or was as good as previously described methods when tested on 102 proteins from the Directory of Useful Decoys, Enhanced (DUD-E). We used RIDGE and RIDE to screen ultralarge virtual libraries against challenging cancer targets, PD-L1 and K-Ras G12D. This led to the discovery of novel inhibitors with single-digit to submicromolar affinities (five for PD-L1, three for K-Ras G12D). Docking scores from our methods were better predictors of binding than conventional VLS. These novel GPU-accelerated methods expand screenable chemical space and successfully identify active hits, even for challenging targets. Further optimization and libraries with higher-molecular-weight cutoffs could further improve targeting of nondruggable proteins.
No takes yet. Share an insight, caveat, or question.
Raush et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: